Table 1 Patients characteristics at allogeneic HSCT

Median age, years (range)

62 (36–67)

Gender M/F, number (%)

5 (42)/7 (58)

Diagnosis, number (%)

 Acute Myeloid Leukemia

6 (50)

 Non-Hodgkin´s Lymphoma

3 (25)

 Myelodysplastic Syndrome

2 (17)

 Hodgkin´s Lymphoma

1 (8)

Disease status at HSCT, number (%)

 CR1

4 (33)

 CR2

6 (50)

 PR

2 (17)

Hematopoietic stem cell donor, number (%)

 HLA-identical sibling

6 (50)

 Unrelated donor

6 (50)

Median CD34 + infused, 10⁶/kg (range)

6.47 (4.90–10.41)

Median CD3 + infused, 10⁸/kg (range)

9.92 (6.23–19.61)

Median ECP duration, months (range)

5 (1–12)